ATE224711T1 - Formulierung zur behandlung und/oder vorbeugung von dementia - Google Patents

Formulierung zur behandlung und/oder vorbeugung von dementia

Info

Publication number
ATE224711T1
ATE224711T1 AT97934492T AT97934492T ATE224711T1 AT E224711 T1 ATE224711 T1 AT E224711T1 AT 97934492 T AT97934492 T AT 97934492T AT 97934492 T AT97934492 T AT 97934492T AT E224711 T1 ATE224711 T1 AT E224711T1
Authority
AT
Austria
Prior art keywords
dementia
formulation
prevention
treatment
Prior art date
Application number
AT97934492T
Other languages
English (en)
Inventor
Schie Dirk M J Van
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE224711T1 publication Critical patent/ATE224711T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT97934492T 1996-07-25 1997-07-14 Formulierung zur behandlung und/oder vorbeugung von dementia ATE224711T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9615628.6A GB9615628D0 (en) 1996-07-25 1996-07-25 Formulation
PCT/EP1997/003872 WO1998004258A1 (en) 1996-07-25 1997-07-14 Formulation for the treatment and/or prophylaxis of dementia

Publications (1)

Publication Number Publication Date
ATE224711T1 true ATE224711T1 (de) 2002-10-15

Family

ID=10797487

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97934492T ATE224711T1 (de) 1996-07-25 1997-07-14 Formulierung zur behandlung und/oder vorbeugung von dementia

Country Status (23)

Country Link
EP (1) EP0918521B1 (de)
JP (1) JP2000515868A (de)
KR (1) KR20000029523A (de)
CN (1) CN1226163A (de)
AR (1) AR007983A1 (de)
AT (1) ATE224711T1 (de)
BR (1) BR9710546A (de)
CA (1) CA2261233A1 (de)
CO (1) CO5031290A1 (de)
CZ (1) CZ22799A3 (de)
DE (1) DE69715878T2 (de)
DK (1) DK0918521T3 (de)
ES (1) ES2184121T3 (de)
GB (1) GB9615628D0 (de)
IL (1) IL128095A (de)
NO (1) NO990283L (de)
NZ (1) NZ333704A (de)
PL (1) PL331283A1 (de)
PT (1) PT918521E (de)
TR (1) TR199900141T2 (de)
TW (1) TW426514B (de)
WO (1) WO1998004258A1 (de)
ZA (1) ZA976592B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9815383D0 (en) * 1998-07-15 1998-09-16 Smithkline Beecham Plc Novel method of treatment
KR100854213B1 (ko) * 2000-09-27 2008-08-26 디에스엠 아이피 어셋츠 비.브이. 콘쥬게이션 디엔의 카르보닐화 방법
GB0428170D0 (en) * 2004-12-23 2005-01-26 Biopartners Ltd Mono and Combination Therapy
AU2018398887B2 (en) 2017-12-29 2024-03-14 Guangzhou Maxinovel Pharmaceuticals Co., Ltd Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and application
WO2026018154A1 (en) 2024-07-16 2026-01-22 Syremis Therapeutics Ltd. Combinations of sabcomeline with non-cns penetrant muscarinic antagonists
WO2026018155A1 (en) 2024-07-16 2026-01-22 Syremis Therapeutics Ltd. Combinations of sabcomeline with long-acting non-cns penetrant muscarinic antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE269330T1 (de) * 1989-04-13 2004-07-15 Beecham Group Plc Chemische verbindungen
MX9300875A (es) * 1992-02-20 1993-08-31 Smithkline Beecham Plc Procedimiento para la preparacion de compuestos azabiciclicos.
GB9409705D0 (en) * 1994-05-14 1994-07-06 Smithkline Beecham Plc Novel compounds
DE19501022C1 (de) * 1995-01-14 1996-06-05 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
IL128095A (en) 2002-07-25
TR199900141T2 (xx) 1999-03-22
HK1021314A1 (en) 2000-06-09
IL128095A0 (en) 1999-11-30
PL331283A1 (en) 1999-07-05
CA2261233A1 (en) 1998-02-05
NZ333704A (en) 2000-06-23
NO990283L (no) 1999-03-19
JP2000515868A (ja) 2000-11-28
CN1226163A (zh) 1999-08-18
NO990283D0 (no) 1999-01-22
TW426514B (en) 2001-03-21
AU3768497A (en) 1998-02-20
BR9710546A (pt) 1999-08-17
ZA976592B (en) 1999-03-04
KR20000029523A (ko) 2000-05-25
AU721101B2 (en) 2000-06-22
CZ22799A3 (cs) 1999-06-16
CO5031290A1 (es) 2001-04-27
DE69715878D1 (de) 2002-10-31
DE69715878T2 (de) 2003-05-22
EP0918521B1 (de) 2002-09-25
ES2184121T3 (es) 2003-04-01
AR007983A1 (es) 1999-11-24
EP0918521A1 (de) 1999-06-02
GB9615628D0 (en) 1996-09-04
PT918521E (pt) 2003-02-28
DK0918521T3 (da) 2003-02-03
WO1998004258A1 (en) 1998-02-05

Similar Documents

Publication Publication Date Title
DE69733329D1 (de) Verwendung von Taurin zur Behandlung oder Vorbeugung von ischämischen Verletzungen
ATE201138T1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung und prophylaxe der multiplen sclerose
DE69832838D1 (de) Vorrichtung zur Aufbewahrung und/oder Behandlung von Chemikalien
DE69739758D1 (de) Vakzine zur behandlung von lymphomen und leukämie
ATE275383T1 (de) Oxadisäuren und verwandte verbindungen zur behandlung von hautstörungen
DE69312624D1 (de) Vorrichtung zur unterscheidung von tachykardien und fibrillationen und zur entsprechenden behandlung
DE69942680D1 (de) Verfahren und Zusammensetzungen zur Prävention und Behandlung von Anämie
DE69823459D1 (de) Herzbehandlungssystem zur Feststellung und Behandlung von Herzversagen
DE69806579D1 (de) Anlage zur behandlung von nahrungsmitteln
DE69332732D1 (de) Pharmazeutische Zusammensetzung und Methode zur Behandlung von Hyperlipidämie und Arterioskerose
DE69836752D1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
DE69432299D1 (de) Multiple Botulinum Toxine zur Behandlung von neuromuskulären Störungen und Zuständen
ATA11989A (de) Mittel zur vorbeugung gegen und behandlung von parodontopathien
DE69806801D1 (de) Galenische präparation zur prävention und behandlung von hepatokarzinomen
DE69812784D1 (de) Zusammensetzung zur Vorbeugung und Beseitigung von Pflanzenkrankheiten
DE69422842D1 (de) Verfahren und Einrichtung zur Behandlung von Lithium
DE69115921D1 (de) Verfahren zur behandlung und verwendung von abfallstoffen
EP1043983A4 (de) Tetracycline und/oder tetracyclinderivate zur behandlung und prophylaxe von cerebrovascularen krankheiten des nervensystems
DE69532066D1 (de) Arzneimittel zur Behandlung von Restenosis und Gefässsklerose
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
DE69841550D1 (de) Behandlung von fibromyalgie und verwandten erkrankungen
DE69429101D1 (de) Verbindungen und zusammensetzungen zur behandlung von allergien und entzündungen
ATE347372T1 (de) Vakzine zur behandlung von mycosen
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
DE69625883D1 (de) Zusammensetzung zur Reinigung und/oder Desinfektion von medizinischen Geräten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0918521

Country of ref document: EP

REN Ceased due to non-payment of the annual fee